Prophylactic Cannabinoid Administration Blocks the Development of Paclitaxel-Induced Neuropathic Nociception during Analgesic Treatment and following Cessation of Drug Delivery
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prophylactic Cannabinoid Administration Blocks the Development of Paclitaxel-Induced Neuropathic Nociception during Analgesic Treatment and following Cessation of Drug Delivery
Authors
Keywords
Cannabinoid, CB<sub>1</sub>, CB<sub>2</sub>, Chemotherapy, Cold allodynia, Mechanical allodynia, Osmotic mini pump, Paclitaxel
Journal
Molecular Pain
Volume 10, Issue -, Pages 1744-8069-10-27
Publisher
SAGE Publications
Online
2014-04-18
DOI
10.1186/1744-8069-10-27
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bilateral Changes of Cannabinoid Receptor Type 2 Protein and mRNA in the Dorsal Root Ganglia of a Rat Neuropathic Pain Model
- (2013) Ivana Hradilová Svíženská et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain
- (2013) Mary E. Lynch et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Glia and pain: Is chronic pain a gliopathy?
- (2013) Ru-Rong Ji et al. PAIN
- Cannabinoid CB2 Receptors Regulate Central Sensitization and Pain Responses Associated with Osteoarthritis of the Knee Joint
- (2013) James J. Burston et al. PLoS One
- Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central Cannabinoid Type 2 Receptor System
- (2012) Mohamed Naguib et al. ANESTHESIA AND ANALGESIA
- Evidence That Spinal Astrocytes but Not Microglia Contribute to the Pathogenesis of Paclitaxel-Induced Painful Neuropathy
- (2012) Haijun Zhang et al. JOURNAL OF PAIN
- The Maintenance of Cisplatin- and Paclitaxel-Induced Mechanical and Cold Allodynia is Suppressed by Cannabinoid CB2 Receptor Activation and Independent of CXCR4 Signaling in Models of Chemotherapy-Induced Peripheral Neuropathy
- (2012) Liting Deng et al. Molecular Pain
- Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: Effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment
- (2012) Josée Guindon et al. PHARMACOLOGICAL RESEARCH
- The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries
- (2011) F.Y. Zheng et al. NEUROSCIENCE
- Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects
- (2011) Elizabeth J. Rahn et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Pharmacological Characterization of a Novel Cannabinoid Ligand, MDA19, for Treatment of Neuropathic Pain
- (2010) Jijun J. Xu et al. ANESTHESIA AND ANALGESIA
- Chemotherapy-Induced Peripheral Neuropathy as a Predictor of Neuropathic Pain in Breast Cancer Patients Previously Treated With Paclitaxel
- (2009) Cielito C. Reyes-Gibby et al. JOURNAL OF PAIN
- Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain
- (2009) S. G. Kinsey et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Animal models of chemotherapy-evoked painful peripheral neuropathies
- (2009) Nicolas Authier et al. Neurotherapeutics
- Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside
- (2009) Elizabeth J. Rahn et al. Neurotherapeutics
- MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models
- (2008) M Naguib et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mechanisms Underlying Chemotherapy-Induced Neurotoxicity and the Potential for Neuroprotective Strategies
- (2008) S. Park et al. CURRENT MEDICINAL CHEMISTRY
- Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies
- (2008) Sherry Wolf et al. EUROPEAN JOURNAL OF CANCER
- Pharmacokinetics and Pharmacodynamics of LGD-3303 [9-Chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo-[3,2-f]quinolin-7(6H)-one], an Orally Available Nonsteroidal-Selective Androgen Receptor Modulator
- (2008) E. G. Vajda et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats
- (2008) E. J. Rahn et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats
- (2007) E J Rahn et al. BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now